Year 2023 Vol. 31 No 6

REVIEWS

N.M. GREKOVA, Y.V. NAIMUSHINA, O.S. SLEPYKH, S.S. ANUFRIEVA, V.V. BELOV, D.N. SADARDINOV, S.F. KUBASOV

GASTROINTESTINAL STRICTURES IN CROHN’S DISEASE: SURGICAL TECHNIQUE

South Ural State Medical University, Chelyabinsk
Russian Federation

The prevalence of Crohn’s disease (CD) in the European population is high – 322 per 100,000 people. Primary or recurrent fibrous stricture in one or more parts of the gastrointestinal (GI) tract is the most frequent complication of CD (21-29.4%), which requires surgical treatment performed as emergency or planned. Stricture recurrences after resection intervention during 10 years of follow-up occur in 35% of cases and require repeated operations. Repeated resections worsen the quality of life, often require preventive stomas, lead to the development of short bowel syndrome, malabsorption, maldigestion. Recurrence rate after stricturoplasty is 28.9%. Nowadays alternative antistricture and antirecurrence resection and anastomotic techniques for surgery for CD strictures, as well as organ-preserving minimally invasive endoscopic interventions are offered along with traditional ones. This review focuses on modern methods of surgical treatment of CD strictures. The justified choice of surgical treatment of strictures of esophagus, stomach and duodenum, small and large intestine allows to improve the quality of life of operated patients with CD complicated by primary and recurrent strictures of these GI parts.

Keywords: Crohn’s disease/surgery, constriction, fibrosis, recurrence, endoscopy
p. 478-490 of the original issue
References
  1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012 Jan;142(1):46-54. doi: 10.1053/j.gastro.2011.10.001.
  2. Dolgushina AI, Khusainova GM, Vasilenko AG, Kononets VA. Prevalence of inflammatory bowel diseases in the Chelyabinsk region. Almanac of Clinical Medicine. 2019; 47(6):511-517. doi: 10.18786/2072-0505-2019-47-066.(In Russ.)
  3. Yanni F, Ling Z, Negar O, Rhonda LB, Jennifer ST, Kimberly GB, Parakkal D. Patients With Stricturing or Penetrating Crohn’s Disease Phenotypes Report High Disease Burden and Treatment Needs. Inflammatory Bowel Diseases, 2023 Jun;29(6):914-922. doi: 10.1093/ibd/izac162.
  4. Starostin AM, Vorobey AV, Shuleiko AC. Crohn’s disease: options and results of surgical treatment, predictors of postoperative complications. Surgery. Eastern Europe. 2023, Apr 12(1):37-47. doi: 10.34883/PI.2023.12.1.014. .(In Russ.)
  5. Burisch J, Kiudelis G, Kupcinskas L, Kievit HAL, Andersen KW, Andersen V, Salupere R, Pedersen N, Kjeldsen J, D’Incà R, Valpiani D, Schwartz D, Odes S, Olsen J, Nielsen KR, Vegh Z, Lakatos PL, Toca A, Turcan S, Katsanos KH, Christodoulou DK, Fumery M, Gower-Rousseau C, Zammit SC, Ellul P, Eriksson C, Halfvarson J, Magro FJ, Duricova D, Bortlik M, Fernandez A, Hernández V, Myers S, Sebastian S, Oksanen P, Collin P, Goldis A, Misra R, Arebi N, Kaimakliotis IP, Nikuina I, Belousova E, Brinar M, Cukovic-Cavka S, Langholz E, Munkholm P; Epi-IBD group. Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. 2019 Mar;68(3):423-433. doi: 10.1136/gutjnl-2017-315568.
  6. Aksan A, Farrag K, Blumenstein I, Schröder O, Dignass AU, Stein J. Chronic intestinal failure and short bowel syndrome in Crohn’s disease. World J Gastroenterol. 2021 Jun 28;27(24):3440-3465. doi: 10.3748/wjg.v27.i24.3440.
  7. De Felice KM, Katzka DA, Raffals LE. Crohn’s Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era. Inflamm Bowel Dis. 2015;21(9):2106-2113. doi: 10.1097/MIB.0000000000000469.
  8. Wespi SP, Frei R, Sulz MC. A Very Rare Cause of a Relapsing Para-Oesophageal Abscess. Case Rep Gastroenterol. 2016 May 19;10(1):132-8. doi: 10.1159/000445183.
  9. Loreto-Brand M, Fernández-Pérez A, Celeiro-Muñoz C, Álvarez-Castro A, Bustamante-Montalvo M. Crohn’s disease: Upper gastrointestinal involvement. Rev Gastroenterol Mex. 2015;80(4):282-285. doi: 10.1016/j.rgmx.2015.03.004.
  10. Nomura Y, Moriichi K, Fujiya M, Okumura T. The endoscopic findings of the upper gastrointestinal tract in patients with Crohn’s disease. Clin J Gastroenterol. 2017;10(4):289-296. doi: 10.1007/s12328-017-0759-7.
  11. Ammoury RF, Pfefferkorn MD. Significance of esophageal Crohn disease in children. J Pediatr Gastroenterol Nutr. 2011;52(3):291-294. doi: 10.1097/MPG.0b013e3181ec21b5.
  12. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, IBD guidelines eDelphi consensus group, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:1-106. doi: 10.1136/gutjnl-2019-318484.
  13. Henriksen M, Jahnsen J, Lygren I, Aadland E, Schulz T, Vatn MH, Moum B, Ibsen Study Group. Clinical course in Crohn’s disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007 May;42(5):602-10. doi: 10.1080/00365520601076124.
  14. Decker GA, Loftus EV Jr, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn’s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7(2):113-119. doi: 10.1097/00054725-200105000-00006.
  15. Naranjo-Rodríguez A, Solórzano-Peck G, López-Rubio F, Calañas-Continente A, Gálvez-Calderón C, González-Galilea A, Hervás-Molina A. Isolated oesophageal involvement of Crohn’s disease. Eur J Gastroenterol Hepatol. 2003;15(10):1123-1126. doi: 10.1097/00042737-200310000-00010.
  16. Fichera A, McCormack R, Rubin MA, Hurst RD, Michelassi F. Long-term outcome of surgically treated Crohn’s colitis: a prospective study. Dis Colon Rectum. 2005 May;48(5):963-9. doi: 10.1007/s10350-004-0906-3.
  17. Shapiro M, Greenstein AJ, Byrn J, Corona J, Greenstein AJ, Salky B, Harris MT, Divino CM. Surgical management and outcomes of patients with duodenal Crohn’s disease. J Am Coll Surg. 2008 Jul;207(1):36-42. doi: 10.1016/j.jamcollsurg.2007.12.049.
  18. Rieder F, Bettenworth D, Ma C, Parker CE, Williamson LA, Nelson SA, van Assche G, Di Sabatino A, Bouhnik Y, Stidham RW, Dignass A, Rogler G, Taylor SA, Stoker J, Rimola J, Baker ME, Fletcher JG, Panes J, Sandborn WJ, Feagan BG, Jairath V. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn’s disease. Aliment Pharmacol Ther. 2018 Aug;48(3):347-357. doi: 10.1111/apt.14853.
  19. Limmer AM, Koh HC, Gilmore A. Stricturoplasty-a bowel-sparing option for long segment small bowel Crohn’s disease. J Surg Case Rep. 2017 Aug 22;2017(8):rjx163. doi: 10.1093/jscr/rjx163.
  20. Lagodich NA, Fateeva OA, Vorobey AV, Starostin AM. The role of endoscopic examination methods in the diagnosis of Crohn’s disease. Medical news, No. 4 (307): 30-34. 2020, URL: https://cyberleninka.ru/article/n/rol-endoskopicheskih-metodov-obsledovaniya-v-diagnostike-bolezni-krona (In Russ.)
  21. Gu YB, Zhong J, Chinese IBD Endoscopic Club. Endoscopic management of stricturing Crohn’s disease. J Dig Dis. 2020 Jun;21(6):351-354. doi: 10.1111/1751-2980.12914.
  22. Schulberg JD, Wright EK, Holt BA, Wilding HE, Hamilton AL, Ross AL, Kamm MA. Efficacy of drug and endoscopic treatment of Crohn’s disease strictures: A systematic review. J Gastroenterol Hepatol. 2021 Feb;36(2):344-361. doi: 10.1111/jgh.15330.
  23. Moutzoukis M, Argyriou K, Kapsoritakis A, Christodoulou D. Endoscopic luminal stenting: Current applications and future perspectives. World J Gastrointest Endosc. 2023 Apr 16;15(4):195-215. doi: 10.4253/wjge.v15.i4.195.
  24. Rodrigues C, Oliveira A, Santos L, Pires E, Deus J. Biodegradable stent for the treatment of a colonic stricture in Crohn’s disease. World J Gastrointest Endosc. 2013 May 16;5(5):265-9. doi: 10.4253/wjge.v5.i5.265.
  25. Hendel J, Karstensen JG, Vilmann P. Serial intralesional injections of infliximab in small bowel Crohn’s strictures are feasible and might lower inflammation. United European Gastroenterol J. 2014 Oct;2(5):406-12. doi: 10.1177/2050640614547805.
  26. Shen B, Kochhar G, Navaneethan U, Liu X, Farraye FA, Gonzalez-Lama Y, Bruining D, Pardi DS, Lukas M, Bortlik M, Wu K, Sood A, Schwartz DA, Sandborn WJ, Global Interventional Inflammatory Bowel Disease Group. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group. Gastrointest Endosc. 2019 Feb;89(2):215-237. doi: 10.1016/j.gie.2018.09.045.
  27. Strong SA. Strictureplasty in Complex Crohn’s Disease: Beyond the Basics. Clin Colon Rectal Surg. 2019 Jul;32(4):243-248. doi: 10.1055/s-0039-1683905.
  28. Kachanova TV, Veselov VV, Tarasov MA, Likutov AA, Chernyshov SV. Endoscopic procedures for colorectal anastomoses strictures (review). Koloproktologia. 2020;19(3):113-125. doi: 10.33878/2073-7556-2020-19-3-113-125 (In Russ.)
  29. Vardanyan AV, Toboeva MKh, Zarodnyuk IV, Orlova LP. Strictureplasty as an organ-saving method in patients with small bowel crohn’s disease (case report). Koloproktologia. 2019; v. 18, ¹ 3(69), pp. 77-83. doi: 10.33878/2073-7556-2019-18-3-77-83. (In Russ.)
  30. Fazi M, Giudici F, Luceri C, Pronestì M, Tonelli F. Long-term Results and Recurrence-Related Risk Factors for Crohn Disease in Patients Undergoing Side-to-Side Isoperistaltic Strictureplasty. JAMA Surg. 2016 May 1;151(5):452-60. doi: 10.1001/jamasurg.2015.4552.
  31. Brown C. Heineke-Mikulicz and Finney strictureplasty in Crohn’s disease. Oper Tech Gen Surg 2007;9:3–7. doi: 10.1053/j.optechgensurg.2007.03.002
  32. Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2007 Nov;50(11):1968-86. doi: 10.1007/s10350-007-0279-5.
  33. Poggioli G, Laureti S, Pierangeli F, Ugolini F. A new model of strictureplasty for multiple and long stenoses in Crohn’s ileitis: side-to-side diseased to disease-free anastomosis. Dis Colon Rectum. 2003 Jan;46(1):127-30. doi: 10.1007/s10350-004-6508-2.
  34. Maggiori L, Michelassi F. How I do it: Side-to-side isoperistaltic strictureplasty for extensive Crohn’s disease. J Gastrointest Surg. 2012 Oct;16(10):1976-80. doi: 10.1007/s11605-012-1891-9.
  35. Ñòàðîñòèí ÀÌ, Âîðîáåé ÀÂ. Ñîâðåìåííàÿ õèðóðãè÷åñêàÿ òàêòèêà ïðè àáäîìèíàëüíîì âàðèàíòå áîëåçíè Êðîíà. «Õèðóðãèÿ. Âîñòî÷íàÿ Åâðîïà», 2022, òîì 11, ¹1: 83-83. doi: 10.34883/PI.2022.11.1.007.
  36. Starostin AM, Vorobei AV. Modern Surgical Tactics for Abdominal Crohn’s Disease. Surgery. Eastern Europe, 2022, 11(1): 83-83. doi: 10.34883/PI.2022.11.1.007.(In Russ.)
  37. McLeod RS, Wolff BG, Ross S, Parkes R, McKenzie M, Investigators of the CAST Trial. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2009 May;52(5):919-27. doi: 10.1007/DCR.0b013e3181a4fa58.
  38. Hota S, Parascandola S, Smith S, Tampo MM, Amdur R, Obias V. Robotic and laparoscopic surgical techniques in patients with Crohn’s disease. Surg Endosc. 2021 Aug;35(8):4602-4608. doi: 10.1007/s00464-020-07885-x.
  39. Kono T, Fichera A. Surgical Treatment for Crohn’s Disease: A Role of Kono-S Anastomosis in the West. Clin Colon Rectal Surg. 2020 Nov;33(6):335-343. doi: 10.1055/s-0040-1714236.
  40. Saeed M, Algahiny AT, Elmitwalli OSMMS, Ahmed MMMRM, Juma IM. An Analysis of the Literature and a Case Study on the Successful Surgical Treatment of a Crohn’s Patient Using a Kono-S Anastomosis. Euroasian J Hepatogastroenterol. 2023 Jan-Jun;13(1):36-39. doi: 10.5005/jp-journals-10018-1392.
  41. Teeuwen PH, Stommel MW, Bremers AJ, van der Wilt GJ, de Jong DJ, Bleichrodt RP. Colectomy in patients with acute colitis: a systematic review. J Gastrointest Surg. 2009 Apr;13(4):676-86. doi: 10.1007/s11605-008-0792-4.
  42. Tøttrup A, Erichsen R, Sværke C, Laurberg S, Srensen HT. Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study. BMJ Open. 2012 Apr 5;2(2):e000823. doi: 10.1136/bmjopen-2012-000823.
  43. Rottoli M, Vallicelli C, Bigonzi E, Gionchetti P, Rizzello F, Di Simone MP, Poggioli G. Prepouch Ileitis After Ileal Pouch-anal Anastomosis: Patterns of Presentation and Risk Factors for Failure of Treatment. J Crohns Colitis. 2018 Feb 28;12(3):273-279. doi: 10.1093/ecco-jcc/jjx140.
  44. Kiran RP, Nisar PJ, Church JM, Fazio VW. The role of primary surgical procedure in maintaining intestinal continuity for patients with Crohn’s colitis. Ann Surg. 2011 Jun;253(6):1130-5. doi: 10.1097/SLA.0b013e318212b1a4.
  45. Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: a systematic review. Gut. 2013;62(7):1072-1084. doi: 10.1136/gutjnl-2012-304353.
  46. Shelygin YuA, Ivashkin VT, Achkasov SI, Reshetov IV, Maev IV, Belousova EA, Vardanyan AV, Nanaeva BA, Adamyan LV, Drapkina OM, Namazova-Baranova LS, Razumovsky AYu, Revishvili ASh, Khatkov IE, Shabunin AV, Livzan MA, Sazhin AV, Timerbulatov VM, Khlynova OV, Abdulganieva DI, Abdulkhakov RA, Aleksandrov TL, Alekseeva OP, Alekseenko SA, Anosov IS, Bakulin IG, Barysheva OYu, Bolikhov KV, Veselov VV, Golovenko OV, Gubonina IV, Dolgushina AI, Zhigalova TN, Kagramanova AV, Kashnikov VN, Knyazev OV, Kostenko NV, Likutov AA, Lomakina EY, Loranskaya ID, Mingazov AF, Moskalev AI, Nazarov IV, Nikitina NV, Odintsova AH, Omelyanovsky VV, Osipenko MF, Îshchepkov ÀV, Pavlenko VV, Poluektova EA, Rodoman GV, Segal AM, Sitkin SI, Skalinskaya MI, Surkov AN, Sushkov OI, Tarasova LV, Uspenskaya YuB, Frolov SA, Chashkova EYu, Shifrin OS, Shcherbakova OV, Shchukina OB, Shkurko TV, Makarchuk PA. Clinical guidelines. Crohn’s disease (Ê50), adults. Koloproktologia. 2023;22(3):10-49. doi: 10.33878/2073-7556-2023-22-3-10-49 (In Russ.)
  47. Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d’Hoore A, Pellino G, Dignass AU. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. J Crohns Colitis. 2016 Aug;10(8):873-85. doi: 10.1093/ecco-jcc/jjw055.
  48. Loras C, Andújar X, Gornals JB, Sanchiz V, Brullet E, Sicilia B, Martín-Arranz MD, Naranjo A, Barrio J, Dueñas C, Foruny JR, Busquets D, Monfort D, Pineda JR, González-Huix F, Pérez-Roldán F, Pons V, González B, Reyes Moreno J, Sainz E, Guardiola J, Bosca-Watts MM, Fernández-Bañares F, Mayor V, Esteve M; Grupo Español de Trabajo de la Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn’s disease (ProtDilat study): an open-label, multicentre, randomised trial. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):332-341. doi: 10.1016/S2468-1253(21)00386-1.
  49. Scotti GB, Lorenzetti R, Aratari A, Lamazza A, Fiori E, Papi C, Festa S. Stricturing Crohn’s disease: what is the role of endoscopic stenting? A systematic review. Clin Endosc. 2023 Nov;56(6):726-734. doi: 10.5946/ce.2023.059.
  50. Zhang LJ, Lan N, Wu XR, Shen B. Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients. Gastroenterol Rep (Oxf). 2019 Oct 21;8(2):143-150. doi: 10.1093/gastro/goz051.
  51. Lovasz BD, Lakatos L, Golovics PA, David G, Pandur T, Erdelyi Z, Balogh M, Szita I, Molnar C, Komaromi E, Vegh Z, Mandel MD, Kiss LS, Lakatos PL. Risk of colorectal cancer in Crohn’s disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary. J Gastrointestin Liver Dis. 2013 Sep;22(3):265-8. URL: https://www.jgld.ro/jgld/index.php/jgld/article/view/2013.3.7/618
Address for correspondence:
454092, Russian Federation,
Chelyabinsk Region, Chelyabinsk, Vorovskij st., 64,
South Ural State Medical University,
Department of Faculty Surgery,
tel. +7-922-231-89-11,
e-mail: lebedevareg@mail.ru,
Naimushina Yuliana V.
Information about the authors:
Grekova Natalia M., PhD, Associate Professor, Associate Professor of the Department of Faculty Surgery, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0000-0002-3364-7201
Naimushina Yuliana V., PhD, Associate Professor, Associate Professor of the Department of Faculty Surgery, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0000-0002-6032-3501
Slepykh Oksana S., PhD, Associate Professor of the Department of Faculty Surgery, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0009-0006-3291-0756
Anufrieva Svetlana S., MD, Associate Professor, Head of the Department of Faculty Surgery, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0000-0002-3921-5266
Belov Vadim V., PhD, Associate Professor of the Department of Faculty Surgery, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0009-0009-2501-0532
Sadardinov David N., 6th year student, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0000-0002-7820-6493
Saveliy Fedorovich K., 6th year student, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0000-0001-8636-4590
Kubasov Savely F., 6th year student, South Ural State Medical University, Chelyabinsk, Russian Federation.
http://orcid.org/0000-0001-8636-4590
Contacts | ©Vitebsk State Medical University, 2007-2023